KFF Examines How Abortion Bans, Misinformation, and State Actions May Affect Access to Contraception
Following the Supreme Court’s ruling overturning Roe v. Wade, uncertainty has emerged over whether the right to contraception could also be limited.
View the Latest: Contraception
Filter
-
-
Addressing Misinformation in Rural Communities: Snapshot from the KFF Health Misinformation Tracking Poll Pilot
Poll FindingThis report examines the exposure to, and belief in, health misinformation among people living in rural communities, as well as the media sources they use and the trust they place in health information received from various outlets. It is a companion to the KFF Health Misinformation Tracking Poll Pilot.
-
KFF Examines Challenges in Navigating Coverage for Opill, the First Over-the-Counter Daily Oral Contraceptive Pill, Coming to Market Next Year
News ReleaseAs Opill—the first over-the-counter daily oral contraceptive pill in the United States—is expected to be available for purchase in early 2024, new research conducted by KFF examines barriers to its accessibility for consumers and challenges in providing insurance coverage for it.
-
Insurance Coverage of OTC Oral Contraceptives: Lessons from the Field
ReportThis report is based on 35 structured interviews conducted from January to August 2023, with nearly 80 experts and key players such as pharmacists, health plans, and state Medicaid officials involved in the coverage and provision of OTC contraception in seven states with one or more of these coverage approaches (IL, NJ, NM, NY, OR, UT, and WA). It discusses the challenges and successes in coverage under private health insurance and Medicaid and reviews policy options for operationalizing insurance coverage of non-prescribed OTC contraception such as Opill.
-
KFF Health Misinformation Tracking Poll Pilot
Poll FindingThe poll reveals that at least four in ten U.S. adults saying they’ve heard each of 10 specific false claims about COVID-19, reproductive health, and gun violence. While relatively small shares definitely believes the false claims, many more are uncertain about them. The survey also examines the public’s social and traditional media use and trust in sources of health information.
-
A National Survey of OBGYNs’ Experiences After Dobbs
ReportThis report, based on a nationally representative survey of office-based OBGYNs practicing in the United States, examines the provision of sexual and reproductive health care provided by OBGYNs before and after the Dobbs decision, comparing the experiences of OBGYNs practicing in states where abortion is fully banned, states with gestational restrictions, and states where abortion remains available under most circumstances.
-
New KFF National Survey of OBGYNs Finds Dobbs Decision Has Made It Harder to Treat Miscarriages and Other Pregnancy-Related Emergencies in Affected States; In States with Bans, Half Report Patients Who Were Unable to Obtain an Abortion They Sought
News ReleaseA new KFF survey of office-based OBGYNs finds widespread effects on their practices and patients since the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization one year ago.
-
A Focus on Contraception in the Wake of Dobbs
PerspectiveIn this commentary for Women’s Health Issues, a publication of the Jacobs Institute of Women’s Health, KFF experts discuss contraceptive coverage and financing policies, access points within the delivery system, and the role of mis- and disinformation.
-
KFF Health Tracking Poll May 2023: Health Care in the 2024 Election and in the Courts
FeatureNearly a year after the Supreme Court overturned Roe v. Wade, this poll examines the public's views of abortion and the Supreme Court, and knowledge about mifepristone, a medication abortion drug that is the subject of another court case, the ACA's preventive services provision and HIV in the US.
-
The Title X Network Has Largely Returned Under the Biden Administration
News ReleaseA new KFF brief examines the return of grantees and clinic sites to the Title X network under the Biden Administration, which reversed Trump Administration regulations that prohibited Title X sites from providing abortion referrals and having co-located abortion services.